Drug-induced Adverse Events
Escitalopram Induced Angioedema
Cureus. 2022 Nov 17;14(11):e31600. doi: 10.7759/cureus.31600. eCollection 2022 Nov.
NO ABSTRACT
PMID:36540519 | PMC:PMC9758958 | DOI:10.7759/cureus.31600
Adipose-targeted triiodothyronine therapy counteracts obesity-related metabolic complications and atherosclerosis with negligible side effects
Nat Commun. 2022 Dec 20;13(1):7838. doi: 10.1038/s41467-022-35470-4.
NO ABSTRACT
PMID:36539421 | PMC:PMC9767940 | DOI:10.1038/s41467-022-35470-4
Determination and comparison of potential drug-drug interactions using three different databases in northern cyprus community pharmacies
Niger J Clin Pract. 2022 Dec;25(12):2005-2009. doi: 10.4103/njcp.njcp_448_22.
NO ABSTRACT
PMID:36537458 | DOI:10.4103/njcp.njcp_448_22
Adverse drug reactions of itolizumab in COVID-19 patient: A case report
Indian J Pharmacol. 2022 Sep-Oct;54(5):377-378. doi: 10.4103/ijp.ijp_803_21.
NO ABSTRACT
PMID:36537408 | DOI:10.4103/ijp.ijp_803_21
Analysis of adverse drug reactions of imatinib in chronic myeloid leukemia patients: An Eastern Indian experience
Indian J Pharmacol. 2022 Sep-Oct;54(5):349-352. doi: 10.4103/ijp.ijp_844_21.
NO ABSTRACT
PMID:36537404 | DOI:10.4103/ijp.ijp_844_21
Successful treatment of switching from benzodiazepine to orexin receptor antagonists improves cognitive function in psychiatric disorders: four case reports
Int Clin Psychopharmacol. 2022 Dec 16. doi: 10.1097/YIC.0000000000000450. Online ahead of print.
NO ABSTRACT
PMID:36539372 | DOI:10.1097/YIC.0000000000000450
A phase 1 study of intravenous mitazalimab, a CD40 agonistic monoclonal antibody, in patients with advanced solid tumors
Invest New Drugs. 2022 Dec 20. doi: 10.1007/s10637-022-01319-2. Online ahead of print.
NO ABSTRACT
PMID:36538259 | DOI:10.1007/s10637-022-01319-2
Phase 1 study of safety, pharmacokinetics, and antiviral activity of SARS-CoV-2 neutralizing monoclonal antibody ABBV-47D11 in patients with COVID-19
Pharmacol Res Perspect. 2023 Feb;11(1):e01036. doi: 10.1002/prp2.1036.
NO ABSTRACT
PMID:36537346 | DOI:10.1002/prp2.1036
Characterization and management of adverse events observed with mobocertinib (TAK-788) treatment for <em>EGFR</em> exon 20 insertion–positive non–small cell lung cancer
Expert Rev Anticancer Ther. 2022 Dec 20. doi: 10.1080/14737140.2023.2157815. Online ahead of print.
NO ABSTRACT
PMID:36537204 | DOI:10.1080/14737140.2023.2157815
Liver injury induced by COVID 19 treatment - what do we know?
World J Gastroenterol. 2022 Dec 7;28(45):6314-6327. doi: 10.3748/wjg.v28.i45.6314.
NO ABSTRACT
PMID:36533104 | PMC:PMC9753058 | DOI:10.3748/wjg.v28.i45.6314
Effects of Isoflavone Supplementation on the Response to Medroxyprogesterone in Premenopausal Women with Nonatypical Endometrial Hyperplasia: A Randomized, Double-Blind, Placebo-Controlled Trial
Int J Clin Pract. 2022 Nov 24;2022:1263544. doi: 10.1155/2022/1263544. eCollection 2022.
NO ABSTRACT
PMID:36531558 | PMC:PMC9715344 | DOI:10.1155/2022/1263544
Changes in COVID-19 Vaccine Intent Among a Diverse Population of Older Adults, June 2021-February 2022
Perm J. 2022 Dec 19;26(4):78-84. doi: 10.7812/TPP/22.075. Epub 2022 Oct 31.
NO ABSTRACT
PMID:36530052 | DOI:10.7812/TPP/22.075
Levetiracetam induces severe psychiatric symptoms in people with epilepsy
Seizure. 2022 Dec 14:S1059-1311(22)00278-3. doi: 10.1016/j.seizure.2022.12.002. Online ahead of print.
NO ABSTRACT
PMID:36535885 | DOI:10.1016/j.seizure.2022.12.002
Management of nirmatrelvir/ritonavir and tacrolimus interaction in kidney transplant recipients infected by COVID-19: a three-case series
Eur J Hosp Pharm. 2022 Dec 19:ejhpharm-2022-003544. doi: 10.1136/ejhpharm-2022-003544. Online ahead of print.
NO ABSTRACT
PMID:36535689 | DOI:10.1136/ejhpharm-2022-003544
Pyrotinib combining with radiotherapy on breast cancer with brain metastasis
Exp Biol Med (Maywood). 2022 Dec 19:15353702221142605. doi: 10.1177/15353702221142605. Online ahead of print.
NO ABSTRACT
PMID:36533572 | DOI:10.1177/15353702221142605
A multicenter study on the tolerance of intravenous low-dose cyclophosphamide in systemic lupus erythematosus
Safety and tolerability of short-term infusions of intravenous lacosamide in paediatric patients with epilepsy: An open-label, Phase 2/3 trial
Epilepsia Open. 2022 Dec 18. doi: 10.1002/epi4.12682. Online ahead of print.
NO ABSTRACT
PMID:36529709 | DOI:10.1002/epi4.12682
Dynamic reaction picklist for improving allergy reaction documentation: A usability study
Int J Med Inform. 2022 Dec 5;170:104939. doi: 10.1016/j.ijmedinf.2022.104939. Online ahead of print.
NO ABSTRACT
PMID:36529027 | DOI:10.1016/j.ijmedinf.2022.104939
Diabetes mellitus degenerates cisplatin-induced nephrotoxicity in short hydration method: a propensity score-matching analysis
Sci Rep. 2022 Dec 17;12(1):21819. doi: 10.1038/s41598-022-26454-x.
NO ABSTRACT
PMID:36528725 | PMC:PMC9759552 | DOI:10.1038/s41598-022-26454-x
Phase I studies of the safety, tolerability, pharmacokinetics and pharmacodynamics of the dual glucagon receptor/glucagon-like peptide-1 receptor (GCGR/GLP-1R) agonist BI 456906
Diabetes Obes Metab. 2022 Dec 17. doi: 10.1111/dom.14948. Online ahead of print.
NO ABSTRACT
PMID:36527386 | DOI:10.1111/dom.14948